PROCOMCURE BIOTECH GMBH has a total of 12 patent applications. Its first patent ever was published in 2007. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are G1 THERAPEUTICS INC, ETERNYGEN GMBH and MOEHS IBERICA S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Önder Kamil | 8 |
#2 | Datema Roelf | 8 |
#3 | Kondratov Ivan | 6 |
#4 | Mitchell Dale | 6 |
#5 | Bauer Johann W | 4 |
#6 | Onder Kamil | 2 |
#7 | Oender Kamil | 2 |
Publication | Filing date | Title |
---|---|---|
US2017340613A1 | Imidazole-based heterocyclic compounds | |
WO2016087618A1 | Imidazole-based antimicrobial agents | |
EP2034020A1 | Method for manufacturing a modified peptide |